CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
3.620
+0.150 (4.32%)
At close: May 12, 2025, 4:00 PM
3.620
0.00 (0.00%)
After-hours: May 12, 2025, 5:11 PM EDT
CureVac Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CureVac stock have an average target of 14, with a low estimate of 12 and a high estimate of 16. The average target predicts an increase of 286.74% from the current stock price of 3.62.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CureVac stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +231.49% | Apr 30, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +341.99% | Feb 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +341.99% | Sep 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +341.99% | Aug 16, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +397.24% | Jul 3, 2024 |
Financial Forecast
Revenue This Year
58.09M
from 535.18M
Decreased by -89.15%
Revenue Next Year
80.20M
from 58.09M
Increased by 38.07%
EPS This Year
-0.53
from 0.72
EPS Next Year
-0.41
from -0.53
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 122.6M | 99.8M | 223.0M | ||
| Avg | 58.1M | 80.2M | 216.6M | ||
| Low | n/a | 60.0M | 208.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -77.1% | 71.7% | 178.1% | ||
| Avg | -89.1% | 38.1% | 170.1% | ||
| Low | - | 3.3% | 159.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.12 | -0.13 | 0.36 |
| Avg | -0.53 | -0.41 | -0.01 |
| Low | -0.79 | -0.69 | -0.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.